• First accelerate

    MedFORCE has enrolled its first acceleratee

  • First fund close

  • First investment

    Almond Tree Capital (ATC) has made its first investment with SureClinical and MedFORCE added its second accelerate.

    • 2015

      • Second Closing of Fund I


      • Second Portfolio Company

        Moving Analytics, Inc.


      • Third Portfolio Company

        EvinceMed, Inc.

      • Over 100 Companies carefully evaluated using MedForce Acceleration tools

Portfolio companies:

SureClinical, Inc:

A SaaS company serving the pharmaceutical development clinical trial document management market with its secure, FDA-compliant, mobile-device-enabled, cloud-based software, with highest level authentication ("virtual notary public"), close ties to developing eTMF standards, and the proven ability to save time and money in bringing new therapies to market.



Moving Analytics, Inc:

Evidence-based app and nurse workstation to facilitate home-based cardio-pulmonary rehab at bundled payment cardiac hospitals: raising patient enrollment and completion, reducing readmits, raising reimbursement, lowering costs.



EvinceMed, Inc:

“Intel-inside”-like platform targeting $100B high end drug problem, to expedite eligibility, pre-authorization (EPA), consent. EvinceMed™ Specialty Therapeutics Management Platform connects, automates, and simplifies the holistic specialty prescribing process across healthcare to take time, cost, and frustration out of the system.